Literature DB >> 11079741

Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report.

T Otonkoski1, M Roivainen, O Vaarala, B Dinesen, J A Leipälä, T Hovi, M Knip.   

Abstract

AIMS/HYPOTHESIS: Neonatal diabetes mellitus is rare, and it has not been associated with beta-cell autoimmunity. Enteroviral infections during pregnancy have been implicated as a risk factor for the later development of Type I (insulin-dependent) diabetes mellitus. We now report of a baby girl who was born severely growth-retarded with neonatal insulin-deficient diabetes, and look for evidence of intrauterine enteroviral infections and beta-cell targeted autoimmunity.
METHODS: Diabetes-associated autoimmunity was studied by measurement of several types of islet cell reactive autoantibodies. The infant's T-cell responses to insulin and enterovirus antigens were recorded and enterovirus antibodies were measured both from the mother and the child.
RESULTS: Several types of diabetes-associated autoantibodies were detected postnatally, including insulin autoantibodies, conventional islet cell autoantibodies and glutamic acid decarboxylase antibodies, whereas no autoantibodies were observed in the mother. The infant's T-cells showed reactivity to insulin and purified enterovirus particles. Based on serological studies, the pathogenetic process could have been triggered by an echovirus 6 infection during pregnancy. The patient's diabetes has been permanent, although there were signs of endogenous insulin production for several months. Exocrine pancreatic insufficiency was diagnosed at the age of 1 year. CONCLUSION/
INTERPRETATION: These observations suggests that enteroviral infections may induce beta-cell autoimmunity even in utero.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079741     DOI: 10.1007/s001250051518

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population.

Authors:  Olga Kordonouri; Nicole Shuga; Hadas Lewy; Israel Ashkenazi; Zvi Laron
Journal:  Eur J Pediatr       Date:  2002-03-26       Impact factor: 3.183

Review 2.  Autoimmunity and familial risk of type 1 diabetes.

Authors:  Anu-Maaria Hämäläinen; Mikael Knip
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 3.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

4.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

Authors:  Emma M Haapaniemi; Meri Kaustio; Hanna L M Rajala; Arjan J van Adrichem; Leena Kainulainen; Virpi Glumoff; Rainer Doffinger; Heikki Kuusanmäki; Tarja Heiskanen-Kosma; Luca Trotta; Samuel Chiang; Petri Kulmala; Samuli Eldfors; Riku Katainen; Sanna Siitonen; Marja-Liisa Karjalainen-Lindsberg; Panu E Kovanen; Timo Otonkoski; Kimmo Porkka; Kaarina Heiskanen; Arno Hänninen; Yenan T Bryceson; Raija Uusitalo-Seppälä; Janna Saarela; Mikko Seppänen; Satu Mustjoki; Juha Kere
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

Review 5.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

6.  Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.

Authors:  Toru Kanno; Kisoon Kim; Ken Kono; Kristen M Drescher; Nora M Chapman; Steven Tracy
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Coxsackievirus B4 infection of human fetal thymus cells.

Authors:  Fabienne Brilot; Vincent Geenen; Didier Hober; Cheryl A Stoddart
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16.

Authors:  E Cabrera-Rode; L Sarmiento; C Tiberti; G Molina; J Barrios; D Hernández; O Díaz-Horta; U Di Mario
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

9.  Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial.

Authors:  K Sadeharju; A-M Hämäläinen; M Knip; M Lönnrot; P Koskela; S M Virtanen; J Ilonen; H K Akerblom; H Hyöty
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

10.  Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Richard Caswell; Julian P Shield; Dorothee Deiss; Zdenek Sumnik; Amely Cayssials; Mathias Herr; Anja Loew; Vaughan Lewis; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.